Application Notes
Immuno-oncology
Assaying Immuno-oncology (IO) in 3D Co-culture with VersaGel® and High Content Imaging.
Publications
Molecular Cancer Therapeutics
February 12, 2019 - A simple three-dimensional hydrogel platform enables ex vivo cell culture of patient and PDX tumors for assaying their response to clinically relevant therapies
SLAS 2019 Poster
A novel high-throughput solution for screening drugs with a light-crosslinked VersaGel® 3D tumor culture model and automated high-content imaging
Protocols
If you are a current customer looking to access any licensed protocols, please email support@cypre.co.